Aixcrypto Holdings Inc
AIXC
NASDAQ
Biotechnology
$0.68
USD
-0.01 (-2.01%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $14.71M
Volume 13.9K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 3.0 | 4.2 | 3.0 |
Other Operating Expenses | 4.3 | 0.3 | 0.0 |
Total Operating Expenses | 7.4 | 4.5 | 3.0 |
Operating Income | -7.4 | -4.5 | -3.0 |
EBITDA | -7.4 | -4.3 | -3.0 |
Other Income / Expense | -3.2 | -1.9 | -1.4 |
Total Other Income / Expense | -3.2 | -1.6 | -1.2 |
Income Before Income Taxes | -10.6 | -6.1 | -4.2 |
Income Taxes | -0.0 | 0.0 | 0.0 |
Net Income | -10.6 | -6.1 | -4.2 |
Consolidated Net Income / Loss | -10.6 | -6.1 | -4.2 |
Net Income Attributable to Common Shareholders | -12.3 | -6.1 | -4.2 |
Basic EPS | -$2.09 | -$0.79 | -$0.21 |
Diluted EPS | -$2.09 | -$0.79 | -$0.21 |
Basic Shares Outstanding | 5.9M | 7.7M | 20.3M |
Diluted Shares Outstanding | 5.9M | 7.7M | 20.3M |